Microbiome Special Interest Group & Ferryx Webinar
Ferryx is a recently incorporated University of Bristol spin-out company, which is developing safe, effective bacterial products to prevent and treat gastrointestinal inflammatory illness in humans and animals. Our proprietary strains are carefully selected for their ability to survive and thrive during active GI inflammation and our aim is to develop these strains as food supplements or prescription therapeutics in both human and veterinary healthcare.
About the KTN Microbiome Special Interest Group
The Microbiome Special Interest Group (SIG) aims to accelerate the commercialisation of microbiome-based products and services through community building and knowledge exchange.
SIGN UP here for the mailing list for the Microbiomes Special Interest Group to stay up to date with news and upcoming events.
Follow the link below to find out more about this event and to register.